Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation

被引:588
作者
Montgomery, E
Bronner, MP
Goldblum, JR
Greenson, JK
Haber, MM
Hart, J
Lamps, LW
Lauwers, GY
Lazenby, AJ
Lewin, DN
Robert, ME
Toledano, AY
Shyr, Y
Washington, K
机构
[1] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[3] Cleveland Clin Fdn, Dept Pathol, Cleveland, OH 44195 USA
[4] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[5] MCP Hahnemann Univ, Dept Pathol, Philadelphia, PA USA
[6] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[7] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[8] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[9] Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA
[10] Yale Univ, Dept Pathol, New Haven, CT 06520 USA
[11] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA
[12] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[13] Univ Arkansas, Little Rock, AR 72204 USA
[14] Vanderbilt Univ, Dept Pathol, Nashville, TN USA
[15] Vanderbilt Univ, Dept Prevent Med & Biostat, Nashville, TN USA
关键词
Barrett esophagus; dysplasia; interobserver; variability;
D O I
10.1053/hupa.2001.23510
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Morphologic assessment of dysplasia in Barrett esophagus, despite limitations, remains the basis of treatment. We rigorously tested modified 1988 criteria, assessing intraobserver and interobserver reproducibility. Participants submitted slides of Barrett mucosa negative (BE) and indefinite (IND) for dysplasia, with low-grade dysplasia (LGD) and high-grade dysplasia (HGD), and with carcinoma. Two hundred fifty slides were divided into 2 groups. The first 125 slides were reviewed, without knowledge of the prior diagnoses, on 2 occasions by 12 gastrointestinal pathologists without prior discussion of criteria. Results were analyzed by kappa statistics, which correct for agreement by chance. A consensus meeting was then held, establishing, by group review of the index 125 slides, the criteria outlined herein. The second 125-slide set,vas then reviewed twice by each of the same 12 pathologists, and follow-up kappa statistics were calculated. When statistical analysis was performed using 2 broad diagnostic categories (BE, IND, and LG v HG and carcinoma), intraobserver agreement was near perfect both before and after the consensus meeting (mean kappa = 0.82 and 0.80). Interobserver agreement was substantial (kappa = 0.66) and improved after the consensus meeting (kappa = 0.70; P =.02). When statistical analysis was performed using 4 clinically relevant separations (BE; IND and LCD; HGD; carcinoma), mean intraobserver kappa improved from 0.64 to 0.68 (both substantial) after the consensus meeting, and mean interobserver kappa improved from 0.43 to 0.46 (both moderate agreement). When statistical analysis was performed using 4 diagnostic categories that required distinction between LGD and IND (BE; IND; LGD; HGD and carcinoma), the pre-consensus meeting mean intraobserver kappa was 0.60 (substantial agreement), improving to 0.65 after the meeting (P <.05). Interobserver agreement was poorer, with premeeting and postmeeting mean values unchanged (<kappa> = 0.43 at both times). Interobserver agreement was substantial for HGD/carcinoma (kappa = 0.65) moderate to substantial for BE (kappa = 0.58), fair for LGD (kappa = 0.32), and slight for IND (kappa = 0.15). The intraobserver reproductibility for the diagnosis of dysplasia in BE was substantial. Interobserver reproducibility was substantial at the ends of the spectrum (BE and HG/carcinoma) but slight for IND. Both intraobserver and interobserver variation improved overall after the application of a modified grading system developed at a consensus conference but not in separation of BE, IND, and LGD. The criteria used by the group are presented.
引用
收藏
页码:368 / 378
页数:11
相关论文
共 14 条
[1]
METHODS AND THEORY OF RELIABILITY [J].
BARTKO, JJ ;
CARPENTER, WT .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1976, 163 (05) :307-317
[2]
[3]
DeMeester S R, 1997, Semin Thorac Cardiovasc Surg, V9, P279
[4]
DeMeester T R, 1997, Semin Thorac Cardiovasc Surg, V9, P290
[5]
BARRETTS-ESOPHAGUS, DYSPLASIA, AND ADENOCARCINOMA [J].
HAGGITT, RC .
HUMAN PATHOLOGY, 1994, 25 (10) :982-993
[6]
Barrett's esophagus - The significance of p53 in clinical practice [J].
Ireland, AP ;
Clark, GWB ;
DeMeester, TR .
ANNALS OF SURGERY, 1997, 225 (01) :17-30
[7]
MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA [J].
LANDIS, JR ;
KOCH, GG .
BIOMETRICS, 1977, 33 (01) :159-174
[8]
Ormsby AH, 1998, MODERN PATHOL, V11, p68A
[9]
PHOTODYNAMIC THERAPY FOR TREATMENT OF EARLY ADENOCARCINOMA IN BARRETTS-ESOPHAGUS [J].
OVERHOLT, B ;
PANJEHPOUR, M ;
TEFFTELLAR, E ;
ROSE, M .
GASTROINTESTINAL ENDOSCOPY, 1993, 39 (01) :73-76
[10]
BARRETTS-ESOPHAGUS - PHOTODYNAMIC THERAPY FOR ABLATION OF DYSPLASIA, REDUCTION OF SPECIALIZED MUCOSA, AND TREATMENT OF SUPERFICIAL ESOPHAGEAL CANCER [J].
OVERHOLT, BF ;
PANJEHPOUR, M .
GASTROINTESTINAL ENDOSCOPY, 1995, 42 (01) :64-70